Products
 
Jintrolong
Strengths
Features
How to use
Indications
Follitropin
Strengths
Features
Indication
Jintropin AQ
Strengths
Features
Indications
Advantages
User guide to Jintropin AQ
Jintropin for Injection
Strengths
Features
Indications
User guide to Jintropin
Genfulin
Strengths
Features
Indications
How to use
Filgrastim
Strengths
Features
Indications
How to use
Filgrastim PFS
Strengths
Features
Indications
How to use
Octreotide
Strengths
Features
Indications
How to use
PEG products
Linear PEG Derivatives
Branched PEG Derivatives
Multi-Arm PEG Derivatives
PEG Raw Materials
New Products coming soon
Thymosin
 
You are here: Home >> Products >> Genfulin
 
    

The active ingredient in Genfulin® is molgramostim (recombinant human granulocyte/ macrophage colony-stimulating factor,
rhGM-CSF [rDNA origin]) produced by GenScis patented E.coli secretion technology. Clinical trials show its efficacy in actively accelerating wound healing, increasing wound tearing-resistance, and reducing, even avoiding, scar proliferation in burn
patients. Genfulin® is used in the treatment of deep II-degree burns and wound healing.

Strengths:
          *   100 μg rhGM-CSF/10g/tube

Features:
          *   The worlds only topical rhGM-CSF gel made by patented E.coli secretion technology
          *   The 1st novel and unique formulation to treat burns

Indications:
          *   Deep II-degree burns
          *   Wound healing

How to use:
          *   Apply the gel to the wound after cleaning with sterile saline water. Apply the gel to the inner layer of the wound
dressing directly when needed.
          *   Dose is base on the size of the wound. 100cm2 wound/tube is recommended, once per day. The period of treatment
is from 7 days to 28 days.
          *   Currently, there is no clinical experience for the wound area more than 100 cm2.

 

 
 

吉ICP备14004136号-1               GeneScience Pharmaceuticals Co., Ltd. (GenSci)  All Rights Reserved